US Stock Movement: Iovance surged on October 9 with revenue increase and Amtagvi
Bitget异动解读2026/10/09 14:30Iovance October 9th Surge Analysis
Keywords: Revenue upgrade, Amtagvi
1. On September 29, the company raised its full-year 2026 total revenue guidance from $350 million–$370 million to $410 million–$420 million. The midpoint increased by $55 million, or about 15%, and exceeds the consensus estimate of $402.8 million, driving up revenue expectations.
2. In the second quarter of 2026, the company achieved record product revenue of $99.3 million. Demand in the US market for Amtagvilifileucel and Proleukin was strong. The authorized treatment center network has expanded to about 100 centers, with plans to reach at least 110 by the end of 2026, providing visibility for third and fourth quarter revenues.
(Disclaimer: This content is generated by AI technology summarizing public information and is for reference only; it does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
US Stock Movement | Snap (SNAP.US) rises over 6% as hedge funds urge the introduction of external capital for Specs, potentially unlocking shareholder value
According to news from Zhitong Finance APP, on Friday, Snap (SNAP.US) surged over 6% to $6.24. On the news front, the hedge fund Blue Duck Capital Partners hopes that Snap Inc. will sell part of its Specs business shares to raise funds. Alex Beinfield, Chief Investment Officer of Blue Duck, recently said in a letter to Snap’s board that Snap is "seriously" undervalued, and raising funds for Specs would unlock significant shareholder value. He stated that a financing centered on Specs would help support related expenditures without diluting Snap's share count, while also preserving its cash flow. Moreover, this move is expected to help the company reduce the Specs’ price of about $2,200. He believes that selling 20% of the Specs subsidiary at a valuation of $5 billion would raise $1 billion, enough to support that department's expenses for around two years.
AI data center company Firmus, backed by Nvidia (NVDA.US), cancels IPO amid doubts over its $30 billion valuation and insufficient demand from U.S. investors
According to Zhihui Finance APP, Firmus Grid, an Australian artificial intelligence (AI) data center operator backed by Nvidia (NVDA.US), originally planned to go public with a valuation of around 30 billions USD, which would have made it one of Australia's largest initial public offerings (IPO). However, due to overvaluation, insufficient investor subscription demand, and concerns in the market regarding the massive financing needs of AI infrastructure, this high-profile IPO was ultimately canceled on Friday.
Crypto prices
More
